Ashley Miniet
Family Medicine · Lemont, ILNPI 1467093088
Payments from drug & device makers
Across 651 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$875
- Novo Nordisk$703
- Nestle Healthcare Nutrition Inc.$683
- Lilly USA, LLC$646
- GSK$506
- plus $6K from 37 others
What the payments were for
- Speaking & faculty fees$440%
- Food & beverage$11,093100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,137 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 45 | $54,115 |
| OzempicSemaglutide | 40 | $53,594 |
| JanuviaSitagliptin Phosphate | 50 | $49,843 |
| Dupixent PenDupilumab | 12 | $45,508 |
| EliquisApixaban | 28 | $33,563 |
| MyrbetriqMirabegron | 17 | $20,201 |
| FarxigaDapagliflozin Propanediol | 22 | $20,118 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $18,917 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $16,916 |
| MounjaroTirzepatide | 13 | $14,005 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $8,685 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 13 | $7,036 |
| TrulancePlecanatide | 12 | $6,701 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $5,914 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 154 | $4,648 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet Xr | $64 | $56,87963 claims |
| Boehringer IngelheimJardiance | $300 | $54,11545 claims |
| Novo NordiskOzempic | $703 | $53,59440 claims |
| PfizerEliquis | $333 | $33,56328 claims |
| AstraZenecaFarxiga, Symbicort | $875 | $22,48433 claims |
| Astellas Pharma US IncMyrbetriq | $105 | $20,20117 claims |
| GSKTrelegy Ellipta | $506 | $16,91626 claims |
| Lilly USA, LLCMounjaro | $646 | $14,00513 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $122 | $6,70112 claims |
| AbbVieSynthroid | $2,218 | $1,41517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Lemont
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.